1 |
张雅聪,吕章艳,宋方方,等.全球及我国乳腺癌发病和死亡变化趋势[J].肿瘤综合治疗电子杂志,2021,7(2):14-20.
|
2 |
LI X L, LU J W, ZHANG L X, et al. Clinical implications of monitoring ESR1 mutations by circulating tumor DNA in estrogen receptor positive metastatic breast cancer:a pilot study[J].Transl Oncol,2020,13(2): 321-328.
|
3 |
KLINGE C M. Estrogen receptor interaction with co-activators and co-repressors[J]. Steroids, 2000, 65(5): 227-251.
|
4 |
BOONYARATANAKORNKIT V, HAMILTON N, MÁRQUEZ-GARBÁN D C, et al. Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer[J]. Mol Cell Endocrinol, 2018, 466: 51-72.
|
5 |
WU D P, ZHOU Y, HOU L X, et al. Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway[J]. Int J Biol Sci, 2021, 17(10): 2380-2398.
|
6 |
WEINER M, SKOOG L, FORNANDER T, et al. Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer[J]. Ann Oncol, 2013, 24(8): 1994-1999.
|
7 |
ALKNER S, BENDAHL P O, EHINGER A, et al. Prior adjuvant tamoxifen treatment in breast cancer is linked to increased AIB1 and HER2 expression in metachronous contralateral breast cancer[J]. PLoS One, 2016, 11(3): e0150977.
|
8 |
ZOU Y F, RONG Y M, CHEN Z X, et al. Effects of Huaier extract on ameliorating colitis-associated colorectal tumorigenesis in mice[J]. Onco Targets Ther, 2020, 13: 8691-8704.
|
9 |
周小城,朱安龙.槐耳颗粒抗结直肠癌作用机制的研究进展[J].医学综述,2021,27(20):4041-4045.
|
10 |
WANG W, WANG X L, LI C, et al. Huaier suppresses breast cancer progression via linc00339/miR-4656/CSNK2B signaling pathway[J]. Front Oncol, 2019, 9: 1195.
|
11 |
JI D L, ZHENG W Y, HUANG P, et al. Huaier restrains cholangiocarcinoma progression in vitro and in vivo through modulating lncRNA TP73-AS1 and inducing oxidative stress[J]. Onco Targets Ther, 2020, 13: 7819-7837.
|
12 |
LUAN Y P, LI Y M, ZHU L N, et al. Codonopis bulleynana Forest ex Diels inhibits autophagy and induces apoptosis of colon cancer cells by activating the NF-κB signaling pathway[J]. Int J Mol Med, 2018, 41(3): 1305-1314.
|
13 |
LIU B, PALMFELDT J, LIN L, et al. STAT3 associates with vacuolar H+-ATPase and regulates cytosolic and lysosomal pH[J]. Cell Res, 2018,28(10): 996-1012.
|
14 |
MONTAÑO-SAMANIEGO M, BRAVO-ESTUPIÑAN D M, MÉNDEZ-GUERRERO O, et al. Strategies for targeting gene therapy in cancer cells with tumor-specific promoters[J]. Front Oncol, 2020, 10: 605380.
|
15 |
WU X H, LIU Y, ZHANG E F, et al. Dihydroartemisinin modulates apoptosis and autophagy in multiple myeloma through the P38/MAPK and Wnt/β-catenin signaling pathways[J].Oxid Med Cell Longev, 2020, 2020: 6096391.
|
16 |
HE L R, LEI Y P, HOU J N, et al. Implications of the receptor tyrosine kinase axl in gastric cancer progression[J].Onco Targets Ther,2020,13:5901-5911.
|
17 |
ZHENG X Q, GUO J P, YANG H, et al. Aurora-a is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer[J]. Oncogene, 2014, 33(42): 4985-4996.
|
18 |
BARTELLA V, RIZZA P, BARONE I, et al. Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter[J]. Breast Cancer Res Treat, 2012, 134(2): 569-581.
|
19 |
于 飞, 胡 晶, 陈雪松. 乳腺癌他莫昔芬耐药机制的研究进展[J]. 实用肿瘤学杂志, 2017, 31(2): 160-164.
|
20 |
SU X Y, XU X, LI G L, et al. ER-α36: a novel biomarker and potential therapeutic target in breast cancer[J]. Onco Targets Ther, 2014, 7: 1525-1533.
|
21 |
ZHAO Z F, ZHOU S G, LI W Y, et al. AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma[J]. J Cancer, 2019, 10(21):5212-5222.
|
22 |
SCHIFF R, OSBORNE C K. Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer[J]. Breast Cancer Res, 2005, 7(5): 205-211.
|
23 |
FENSTERMAKER R A, FIGEL S A, QIU J X, et al. Survivin monoclonal antibodies detect survivin cell surface expression and inhibit tumor growth in vivo [J]. Clin Cancer Res, 2018, 24(11): 2642-2652.
|
24 |
OU Q J, WU X J, PENG J H, et al. Endocrine therapy inhibits proliferation and migration, promotes apoptosis and suppresses survivin protein expression in colorectal cancer cells[J]. Mol Med Rep, 2017, 16(5):5769-5778.
|